|Articles|March 2, 2023
- Applied Clinical Trials-03-01-2023
- Volume 32
- Issue 3
Applied Clinical Trials March 2023 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials March 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Population Representation: Everyone Must Play a Partover 2 years ago
The Impact of Trial Design on Interest by Race and Ethnicityover 2 years ago
Tackling Trial Diversity Through Higher Innovation Standardsover 2 years ago
Strategies for Building Greater DE&I in Rare Disease Trialsover 2 years ago
eCOA Systems and the CE Mark: Navigating the Regulationsover 2 years ago
Quality Tolerance Limits: A Review of Industry Trendsover 2 years ago
Diversity Plans, Sharing for Meaningful Changeover 2 years ago
Hints on Looming Changes to European Clinical Trial Rulesover 2 years ago
Is it Time to Adjust Our Approach to Learning?Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
2
Inside the Recruitment Bottlenecks Driving Trial Delays
3
Designing Feasible Protocols with Real-World Data
4
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
